Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-11-16

Clinical Trial Update: Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial of pregabalin for Restless Legs Syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: University of South Florida | Conditions: Restless Legs Syndrome | Phase 4 | Status: WITHDRAWN